Literature DB >> 10495333

Decreased interleukin-12 levels in umbilical cord blood in children who developed acute bronchiolitis.

A Blanco-Quirós1, H González, E Arranz, S Lapeña.   

Abstract

Respiratory syncytial virus (RSV) infection is common in young children, but only a few develop severe bronchiolitis. The relationship between bronchiolitis, asthma, and atopy has been debated for a long time, but the pathogenesis of wheezing remains unclear. A Th1 and Th2-type lymphocyte imbalance seems to be involved in asthma and atopic disease. Serum interleukin-12 (IL-12), IL-10, and soluble CD30 (sCD30) levels were measured by enzyme-linked immunosorbent assay (ELISA) in 23 cord blood samples kept frozen since birth: 11 from normal term newborns who several months later were admitted to the hospital with bronchiolitis, and 12 from newborns who did not develop the disease (controls). The study was also performed on 28 additional children (1-16 months old) suffering an episode of acute bronchiolitis. IL-12 was clearly increased in all cases at birth, but newborns who later developed bronchiolitis showed low IL-12 levels in cord blood compared to newborns who did not develop the disease (median 295 vs. 507 pg/mL; P = 0.001). sCD30 levels were also decreased in the first group (15 vs. 26 U/mL; P = 0.007). During episodes of bronchiolitis, a clear rise of IL-12, IL-10, and sCD30 was observed. None of the factors studied in the acute phase showed statistical differences in children who were later readmitted to the hospital due to repeated wheezing crises. Children who develop acute bronchiolitis with wheezing may have an immunological imbalance that is expressed at the time of delivery by a lower concentration of serum IL-12.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10495333     DOI: 10.1002/(sici)1099-0496(199909)28:3<175::aid-ppul3>3.0.co;2-u

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  7 in total

1.  Role of interleukin-12 and stat-4 in the regulation of airway inflammation and hyperreactivity in respiratory syncytial virus infection.

Authors:  K K Tekkanat; H Maassab; A A Berlin; P M Lincoln; H L Evanoff; M H Kaplan; N W Lukacs
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

2.  Modulation of respiratory syncytial virus-induced prostaglandin E2 production by n-3 long-chain polyunsaturated fatty acids in human respiratory epithelium.

Authors:  Dani-Louise Bryan; Prue Hart; Kevin Forsyth; Robert Gibson
Journal:  Lipids       Date:  2005-10       Impact factor: 1.880

3.  Decreased Toll-like receptor 8 expression and lower TNF-α synthesis in infants with acute RSV infection.

Authors:  Kreso Bendelja; Valerija Vojvoda; Neda Aberle; Jasna Cepin-Bogovic; Alenka Gagro; Gordana Mlinaric-Galinovic; Sabina Rabatic
Journal:  Respir Res       Date:  2010-10-14

Review 4.  Elucidation of pathways driving asthma pathogenesis: development of a systems-level analytic strategy.

Authors:  Michael L Walker; Kathryn E Holt; Gary P Anderson; Shu Mei Teo; Peter D Sly; Patrick G Holt; Michael Inouye
Journal:  Front Immunol       Date:  2014-09-23       Impact factor: 7.561

5.  Does early EBV infection protect against IgE sensitization?

Authors:  Caroline Nilsson; Annika Linde; Scott M Montgomery; Liselotte Gustafsson; Per Näsman; Marita Troye Blomberg; Gunnar Lilja
Journal:  J Allergy Clin Immunol       Date:  2005-08       Impact factor: 10.793

6. 

Authors:  F Freymuth
Journal:  EMC Pediatr       Date:  2011-08-10

Review 7.  Mucosal Immune Responses to Respiratory Syncytial Virus.

Authors:  Megan V C Barnes; Peter J M Openshaw; Ryan S Thwaites
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.